Mónica Vicente-Pascual (Mónica Vicente)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Reduced Graphene Oxide

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

María Armesto, Mathias Charconnet, Jose María Marimón, Cristina Lía Fernández Regueiro, Jia Jia, Tingdong Yan, Ane Sorarrain, Marek Grzeliczak, María Sanromán, Mónica Vicente-Pascual, Boris Klempa, Javier Zubiria, Yuan Peng, Lei Zhang, Jianhua Zhang, Charles Henderson Lawrie
Validation of Rapid and Economic Colorimetric Nanoparticle Assay for SARS-CoV-2 RNA Detection in Saliva and Nasopharyngeal Swabs. Biosensors 13 (2) (2023)
María Armesto, Mathias Charconnet, Jose María Marimón, Cristina Lía Fernández Regueiro, Jia Jia, Tingdong Yan, Ane Sorarrain, Marek Grzeliczak, María Sanromán, Mónica Vicente-Pascual, Boris Klempa, Javier Zubiria, Yuan Peng, Lei Zhang, Jianhua Zhang, Charles Henderson Lawrie
Validation of Rapid and Economic Colorimetric Nanoparticle Assay for SARS-CoV-2 RNA Detection in Saliva and Nasopharyngeal Swabs. Biosensors 13 (2) (2023)
María Armesto, Mathias Charconnet, Jose María Marimón, Cristina Lía Fernández Regueiro, Jia Jia, Tingdong Yan, Ane Sorarrain, Marek Grzeliczak, María Sanromán, Mónica Vicente-Pascual, Boris Klempa, Javier Zubiria, Yuan Peng, Lei Zhang, Jianhua Zhang, Charles Henderson Lawrie
Validation of Rapid and Economic Colorimetric Nanoparticle Assay for SARS-CoV-2 RNA Detection in Saliva and Nasopharyngeal Swabs. Biosensors 13 (2) (2023)
Julen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. Pharmaceutics 13 (6) (2021)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics 13 (9) (2021)